| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 01/01/2014 | EP2678040A1 A system for cargo delivery into the cells |
| 01/01/2014 | EP2678039A1 Bisphosphonate-prodrugs |
| 01/01/2014 | EP2678038A1 Vaccine composition comprising complexed immunostimulatory nucleic acids and antigens packaged with disulfide-linked polyethyleneglycol/peptide conjugates |
| 01/01/2014 | EP2678037A1 Branched linker for protein drug conjugates |
| 01/01/2014 | EP2678036A1 Locally acting pharmaceutical compositions which can be administered by cutaneous application |
| 01/01/2014 | EP2678034A2 Anti-endoglin antibodies and knockin mice expressing novel human/mouse chimeric endoglin |
| 01/01/2014 | EP2678024A1 Cutaneous pharmaceutical compositions for the local treatment of canine atopic dermatitis |
| 01/01/2014 | EP2678008A1 Nanomedicines for early nerve repair |
| 01/01/2014 | EP2678006A1 Packaging of solid pharmaceutical preparations containing the active substance glyceryl trinitrate |
| 01/01/2014 | EP2678000A1 Stabilized granules containing glyceryl trinitrate |
| 01/01/2014 | CN103492420A Hyaluronic acid-protein conjugate and method for preparing same |
| 01/01/2014 | CN103492417A Tumor specific antibodies and uses therefor |
| 01/01/2014 | CN103492411A Mutant interleukin-2 polypeptides |
| 01/01/2014 | CN103491981A Cellular hydration compositions containing cyclodextrins |
| 01/01/2014 | CN103491976A Methods and compositions for treating conditions related to lack of blood supply, shock and neuronal injuries |
| 01/01/2014 | CN103491972A Granules in liquid dosage form |
| 01/01/2014 | CN103491958A Pouch containing nicotine in free salt form |
| 01/01/2014 | CN103491957A Tolerogenic synthetic nanocarriers to reduce immune responses to therapeutic proteins |
| 01/01/2014 | CN103491953A Pharmaceutical preparation |
| 01/01/2014 | CN103491951A Chewable vehicle for mouth absorption |
| 01/01/2014 | CN103491949A Tablet-type composition for oral administration and method for producing same |
| 01/01/2014 | CN103491946A Biodegradable drug delivery compositions |
| 01/01/2014 | CN103491944A Ophthalmic composition with a viscosity enhancement system having two different viscosity enhancing agents |
| 01/01/2014 | CN103483592A Polymer by grafting cyclodextrins onto polylysine and preparation method of polymer |
| 01/01/2014 | CN103483591A Amphipathic comb type polymer with antibody TRC105 and developing agent and preparation method |
| 01/01/2014 | CN103483589A Two-dimensional polyphosphazene nanosheet layer and preparation and application method |
| 01/01/2014 | CN103483583A Novel epsilon-polylysine preparation method |
| 01/01/2014 | CN103483582A Biodegradable polymer vesicle with pH responsiveness, and preparation method and application thereof |
| 01/01/2014 | CN103483466A Preparation method and application of graphene oxide derivative |
| 01/01/2014 | CN103483446A Broad spectrum neutralization monoclonal antibodies or antigen binding fragments thereof of anti-HPV L2 protein, and applications thereof |
| 01/01/2014 | CN103483353A Dithiolopyrrolone compound nanoparticles and preparation method thereof |
| 01/01/2014 | CN103480030A Method for preparing high-strength chitosan hydrogel through thermal gelation-nearly neutral water bath |
| 01/01/2014 | CN103480006A Preparation method and application for multifunctional nanometer diagnosis and treatment agent integrating light emitting/CT/MR multi-mode imaging and tumor hyperthermia |
| 01/01/2014 | CN103479999A Water-soluble automatic temperature control ferrite nano particles of covalent coupling antibody and method for preparing same |
| 01/01/2014 | CN103479998A Pegylated a beta FAB |
| 01/01/2014 | CN103479974A Traditional Chinese medicine for treating chilblain |
| 01/01/2014 | CN103479958A Suppository for curing gynecological diseases and preparation method thereof |
| 01/01/2014 | CN103479674A Intra-gastric floating type cuttlebone sustained release tablet for treating gastric ulcer and preparation method thereof |
| 01/01/2014 | CN103479667A Multi-trace-element injection (II) medicine composition and preparation method thereof |
| 01/01/2014 | CN103479641A 阿昔洛韦组合物 Acyclovir composition |
| 01/01/2014 | CN103479605A Dilutable ibuprofen pharmaceutical composition and preparation method thereof |
| 01/01/2014 | CN103479600A Tacrolimus solid dispersion |
| 01/01/2014 | CN103479599A Valaciclovir hydrochloride capsule preparation and preparation method thereof |
| 01/01/2014 | CN103479598A Preparation method for polyethylene glycol-polyester triblock copolymer drug-loaded nano-micelle |
| 01/01/2014 | CN103479595A Dutasteride-containing soft capsule |
| 01/01/2014 | CN103479594A Imidafenacin film-coated tablet and preparation method thereof |
| 01/01/2014 | CN103479593A Preparation method for omeprazole enteric coated tablet |
| 01/01/2014 | CN103479592A Metformin hydrochloride sustained release tablets and preparation method thereof |
| 01/01/2014 | CN103479589A Cefpodoxime proxetil dispersible tablet and preparation method thereof |
| 01/01/2014 | CN103479588A Famotidine tablets and preparing method thereof |
| 01/01/2014 | CN103479586A Oral formulations of cytidine analogs and methods of use thereof |
| 01/01/2014 | CN103479584A Use of solid carrier particles to improve the processability of pharmaceutical agent |
| 01/01/2014 | CN103479581A 1-[4-[3-amino-4-hydroxy-3-(hydroxymethyl)butyl]phenyl]-1-acetoxime hydrochloride granules and preparation method thereof |
| 01/01/2014 | CN103479578A Pixantrone maleate liposome preparation and preparation process thereof |
| 01/01/2014 | CN103479576A Adriamycin-wrapped polyethyleneimine-polyethylene glycol-creatine copolymer micelle and preparation method thereof |
| 01/01/2014 | CN103479574A Breast injectant used for preventing and treating dry-milk-period dairy cow mastitis and preparation method thereof |
| 01/01/2014 | CN103479573A Preparation methods for polyethylene glycol monomethyl ether-polyester diblock copolymer micelle and drug-loaded micelle |
| 01/01/2014 | CN103479571A Preparation method of sildenafil injection |
| 01/01/2014 | CN103479570A Preparation method of vardenafil injection |
| 01/01/2014 | CN103479569A Ciprofloxacin injection for animals and preparation method thereof |
| 01/01/2014 | CN103479568A Novel hydrochloric acid topotecan intratumor injection preparation composition and preparation method thereof |
| 01/01/2014 | CN103007290B Nano-carrier particle controllable in drug release and preparation method thereof |
| 01/01/2014 | CN102921008B Stable drug composition containing calcium blockers |
| 01/01/2014 | CN102702703B Beta-PMA (Poly (beta-malic acid))/gelatin nanocapsules and preparation method thereof |
| 01/01/2014 | CN102657871B Oral slow release preparation, entrapment material and preparation method |
| 01/01/2014 | CN102657849B Application of toad maggot protein in medicine used for treating cervical cancer |
| 01/01/2014 | CN102657848B Application of toad maggot protein in preparing medicine used for treating colon cancer |
| 01/01/2014 | CN102657606B Lipoic acid injection for intravenous administration |
| 01/01/2014 | CN102603912B Natural pullulan nano drug carrier and method for preparing same |
| 01/01/2014 | CN102600073B Lactate-based fulvestrant or fulvestrant derivative oily preparation and preparation method of oily preparation |
| 01/01/2014 | CN102573912B Method for improving the aqueous solubility of poorly-soluble substances |
| 01/01/2014 | CN102552442B Compound traditional Chinese medicinal dripping pills for treating hyperosteogeny and preparation method thereof |
| 01/01/2014 | CN102504291B pH sensitive type chitosan crosslinking povidone gel and preparation method and application thereof |
| 01/01/2014 | CN102391498B Polyethylene glycol di-fatty acid glyceride derivatives and application thereof to medicine delivery |
| 01/01/2014 | CN102336834B Fully human TNFalpha-Fab antibody and its PEG antibody |
| 01/01/2014 | CN102123737B Conjugates for the administration of biologically active compounds |
| 01/01/2014 | CN101396346B 紫杉醇脂质复合物 Paclitaxel-lipid complexes |
| 01/01/2014 | CN101001646B Stabilized synthetic immunogen delivery system |
| 12/31/2013 | US8618267 PEG-urate oxidase conjugates and use thereof |
| 12/31/2013 | US8618266 Hasylated polypeptides |
| 12/31/2013 | US8618259 Polymer-factor VIII conjugate compositions |
| 12/31/2013 | US8618179 Composition comprising a pesticide and an alkoxylate of 2-propylheptylamine |
| 12/31/2013 | US8618124 Heterobifunctional polymeric bioconjugates |
| 12/31/2013 | US8618086 Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins |
| 12/31/2013 | US8618067 L-sugar colon cleansing agent and uses thereof |
| 12/31/2013 | US8617846 Tumor-specific recognition molecules |
| 12/31/2013 | US8617598 Pharmaceutical compositions comprising colloidal silicon dioxide |
| 12/31/2013 | US8617587 Tasted masked veterinary solid compositions |
| 12/31/2013 | US8617578 Compositions containing topical-active agents and pentyleneglycol |
| 12/31/2013 | US8617566 Composition comprising VLP and amyloid beta peptide |
| 12/31/2013 | US8617544 Compositions and methods for controlling lipid metabolism |
| 12/31/2013 | US8617530 Polymer conjugates of opioid antagonists |
| 12/31/2013 | US8617529 Use of organomodified siloxane block copolymers as care active ingredient for the care of human or animal body parts |
| 12/31/2013 | US8617526 Cosmetic composition, a pharmaceutical composition and a process for preparing said compositions |
| 12/31/2013 | CA2742680C Pharmaceutical compositions for release control of methylphenidate |
| 12/31/2013 | CA2608788C Spot-on formulations for combating parasites |
| 12/31/2013 | CA2596683C Conjugation of streptococcal capsular saccharides |
| 12/31/2013 | CA2545913C An injectable depot gel composition, a method of preparation and use thereof |
| 12/31/2013 | CA2534298C Aryl carbamate oligomers for hydrolyzable prodrugs and prodrugs comprising same |
| 12/31/2013 | CA2523001C Therapeutic use of anti-cs1 antibodies |